Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $738.48 | 41 | 56.1% |
| Gift | $579.00 | 1 | 43.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $579.00 | 1 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $187.25 | 20 | $0 (2021) |
| Ethicon US, LLC | $167.03 | 5 | $0 (2022) |
| Phathom Pharmaceuticals, Inc. | $153.42 | 3 | $0 (2024) |
| Davol Inc. | $30.03 | 1 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $29.22 | 1 | $0 (2023) |
| Takeda Pharmaceuticals America, Inc. | $28.79 | 3 | $0 (2017) |
| Kowa Pharmaceuticals America, Inc. | $25.46 | 1 | $0 (2022) |
| Intuitive Surgical, Inc. | $24.59 | 1 | $0 (2019) |
| Innocoll Incorporated | $22.17 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $183.45 | 4 | Phathom Pharmaceuticals, Inc. ($153.42) |
| 2023 | $29.22 | 1 | Bard Peripheral Vascular, Inc. ($29.22) |
| 2022 | $68.65 | 3 | Ethicon US, LLC ($27.26) |
| 2021 | $64.61 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($42.44) |
| 2019 | $127.60 | 11 | Takeda Pharmaceuticals U.S.A., Inc. ($44.68) |
| 2018 | $198.78 | 13 | Takeda Pharmaceuticals U.S.A., Inc. ($100.13) |
| 2017 | $645.17 | 7 | Allergan Inc. ($579.00) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $123.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/01/2024 | Davol Inc. | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $30.03 | General |
| Category: Surgery | ||||||
| 07/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/06/2023 | Bard Peripheral Vascular, Inc. | BARD MARQUEE (Device) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: Vascular/Oncology | ||||||
| 11/21/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $25.46 | General |
| Category: Pain Management | ||||||
| 08/24/2022 | Ethicon US, LLC | Megadyne (Device), Harmonic | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: Energy | ||||||
| 04/14/2022 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $15.93 | General |
| 10/15/2021 | Innocoll Incorporated | XARACOLL (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: PAIN | ||||||
| 07/21/2021 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/24/2021 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/14/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: SURGERY | ||||||
| 09/12/2019 | Ethicon US, LLC | LINX Reflux Management System (Device) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Endo-Mechanical | ||||||
| 08/15/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Upper GI | ||||||
| 06/13/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: Upper GI | ||||||
| 04/19/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $4.48 | General |
| Category: Upper GI | ||||||
| 03/07/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: Upper GI | ||||||
| 02/28/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 02/21/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: Upper GI | ||||||
| 02/08/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Upper GI | ||||||
| 01/24/2019 | Teleflex LLC | Access Solutions: Weck brand (Device) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Surgical | ||||||
| 01/17/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: Upper GI | ||||||
| 12/14/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: Upper GI | ||||||
| 11/15/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Upper GI | ||||||
| 09/28/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Upper GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 434 | 583 | $258,965 | $78,087 |
| 2022 | 4 | 367 | 500 | $222,336 | $66,746 |
| 2021 | 5 | 353 | 481 | $210,751 | $65,564 |
| 2020 | 4 | 244 | 328 | $132,573 | $43,882 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31579 | Exam to assess movement of vocal cord flaps using an endoscope | Office | 2023 | 212 | 349 | $177,470 | $53,296 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 101 | 101 | $42,451 | $12,737 | 30.0% |
| 70371 | Imaging of voice box with speech evaluation | Office | 2023 | 76 | 82 | $22,602 | $7,235 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 51 | $16,441 | $4,819 | 29.3% |
| 31579 | Exam to assess movement of vocal cord flaps using an endoscope | Office | 2022 | 193 | 314 | $158,102 | $47,269 | 29.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 86 | 86 | $35,888 | $10,512 | 29.3% |
| 70371 | Imaging of voice box with speech evaluation | Office | 2022 | 63 | 72 | $19,297 | $6,302 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 28 | $9,049 | $2,663 | 29.4% |
| 31579 | Examination to assess movement of vocal cord flaps using an endoscope | Office | 2021 | 172 | 287 | $140,759 | $43,954 | 31.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 77 | 77 | $31,758 | $9,935 | 31.3% |
| 70371 | Imaging of voice box with speech evaluation | Office | 2021 | 67 | 75 | $20,408 | $6,862 | 33.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 30 | $9,295 | $2,546 | 27.4% |
| 31571 | Injection of vocal cords using an endoscope with operating microscope or telescope | Facility | 2021 | 11 | 12 | $8,532 | $2,267 | 26.6% |
| 31579 | Examination to assess movement of vocal cord flaps using an endoscope | Office | 2020 | 125 | 193 | $91,560 | $29,810 | 32.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 48 | 48 | $18,943 | $6,408 | 33.8% |
| 70371 | Imaging of voice box with speech evaluation | Office | 2020 | 50 | 64 | $16,094 | $5,700 | 35.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 21 | 23 | $5,975 | $1,964 | 32.9% |
About Dr. Andre Reed, MD
Dr. Andre Reed, MD is a Otolaryngology healthcare provider based in Englewood, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003885393.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andre Reed, MD has received a total of $1,317 in payments from pharmaceutical and medical device companies, with $183.45 received in 2024. These payments were reported across 42 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($738.48).
As a Medicare-enrolled provider, Reed has provided services to 1,398 Medicare beneficiaries, totaling 1,892 services with total Medicare billing of $254,279. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Otolaryngology
- Location Englewood, CO
- Active Since 03/17/2006
- Last Updated 06/01/2023
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1003885393
Products in Payments
- BOTOX THERAPEUTIC - HH (Biological) $579.00
- VOQUEZNA (Drug) $153.42
- Dexilant (Drug) $153.18
- LINX Reflux Management System (Device) $125.06
- GATTEX (Drug) $42.44
- Phasix Mesh (Device) $30.03
- BARD MARQUEE (Device) $29.22
- Megadyne (Device) $27.26
- Seglentis (Drug) $25.46
- Da Vinci Surgical System (Device) $24.59
- XARACOLL (Drug) $22.17
- Amitiza (Drug) $20.42
- Access Solutions: Weck brand (Device) $19.61
- Xhance (Drug) $12.31
- FLEXITOUCH (Device) $11.74
- Instruments-ENT (Device) $10.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Englewood
Blake Szelestey, Md, MD
Otolaryngology — Payments: $2,680
Dr. Kenneth Garay, M.d, M.D
Otolaryngology — Payments: $1,616
Dr. Bryan Ho, Md, MD
Otolaryngology — Payments: $1,264
Dr. Jeffrey Schmidt, Md, MD
Otolaryngology — Payments: $776.88
Paul Van Der Sloot, Md, MD
Otolaryngology — Payments: $680.17
Dr. Geoffrey Tobias, Mo, MO
Otolaryngology